Meyer Handelman Company’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $31.7M | Sell |
1,127,840
-58,975
| -5% | -$1.57M | 0.98% | 36 |
|
|
2025
Q4 | $29.6M | Sell |
1,186,815
-50,802
| -4% | -$1.28M | 0.93% | 37 |
|
|
2025
Q3 | $31.5M | Sell |
1,237,617
-42,830
| -3% | -$1.06M | 1% | 34 |
|
|
2025
Q2 | $31M | Sell |
1,280,447
-11,350
| -0.9% | -$265K | 1.02% | 30 |
|
|
2025
Q1 | $32.7M | Sell |
1,291,797
-9,364
| -0.7% | -$245K | 1.14% | 32 |
|
|
2024
Q4 | $34.5M | Sell |
1,301,161
-89,245
| -6% | -$2.42M | 1.19% | 25 |
|
|
2024
Q3 | $40.2M | Sell |
1,390,406
-32,812
| -2% | -$957K | 1.36% | 22 |
|
|
2024
Q2 | $39.8M | Sell |
1,423,218
-35,805
| -2% | -$986K | 1.4% | 22 |
|
|
2024
Q1 | $40.5M | Buy |
1,459,023
+52,682
| +4% | +$1.46M | 1.42% | 22 |
|
|
2023
Q4 | $40.5M | Sell |
1,406,341
-69,412
| -5% | -$2.1M | 1.58% | 15 |
|
|
2023
Q3 | $49M | Buy |
1,475,753
+87,840
| +6% | +$3.11M | 1.97% | 9 |
|
|
2023
Q2 | $50.9M | Sell |
1,387,913
-1,593
| -0.1% | -$62K | 2.06% | 8 |
|
|
2023
Q1 | $56.7M | Sell |
1,389,506
-8,380
| -0.6% | -$362K | 2.37% | 6 |
|
|
2022
Q4 | $71.6M | Buy |
1,397,886
+3,107
| +0.2% | +$149K | 2.99% | 4 |
|
|
2022
Q3 | $61M | Sell |
1,394,779
-5,800
| -0.4% | -$282K | 2.82% | 5 |
|
|
2022
Q2 | $73.4M | Sell |
1,400,579
-5,274
| -0.4% | -$269K | 3.15% | 5 |
|
|
2022
Q1 | $72.8M | Sell |
1,405,853
-15
| -0% | -$778 | 2.79% | 5 |
|
|
2021
Q4 | $83M | Sell |
1,405,868
-427
| -0% | -$21.2K | 3.09% | 5 |
|
|
2021
Q3 | $60.5M | Sell |
1,406,295
-14,000
| -1% | -$620K | 2.48% | 5 |
|
|
2021
Q2 | $55.6M | Buy |
1,420,295
+17,816
| +1% | +$693K | 2.2% | 7 |
|
|
2021
Q1 | $50.8M | Buy |
1,402,479
+47,365
| +3% | +$1.68M | 2.1% | 7 |
|
|
2020
Q4 | $49.9M | Sell |
1,355,114
-58,182
| -4% | -$2.13M | 2.25% | 6 |
|
|
2020
Q3 | $49.2M | Sell |
1,413,296
-4,284
| -0.3% | -$150K | 2.5% | 6 |
|
|
2020
Q2 | $44M | Buy |
1,417,580
+4,848
| +0.3% | +$165K | 2.34% | 6 |
|
|
2020
Q1 | $43.8M | Buy |
1,412,732
+4,254
| +0.3% | +$145K | 2.69% | 5 |
|
|
2019
Q4 | $52.4M | Sell |
1,408,478
-15,203
| -1% | -$542K | 2.51% | 5 |
|
|
2019
Q3 | $48.5M | Buy |
1,423,681
+4,113
| +0.3% | +$150K | 2.46% | 6 |
|
|
2019
Q2 | $58.3M | Sell |
1,419,568
-111,408
| -7% | -$4.42M | 2.99% | 5 |
|
|
2019
Q1 | $60.3M | Sell |
1,530,976
-3,689
| -0.2% | -$148K | 3.14% | 4 |
|
|
2018
Q4 | $63.6M | Sell |
1,534,665
-70,223
| -4% | -$2.92M | 3.59% | 3 |
|
|
2018
Q3 | $67.1M | Sell |
1,604,888
-68,985
| -4% | -$2.66M | 3.28% | 3 |
|
|
2018
Q2 | $57.6M | Sell |
1,673,873
-11,489
| -0.7% | -$393K | 2.95% | 4 |
|
|
2018
Q1 | $56.7M | Sell |
1,685,362
-11,565
| -0.7% | -$398K | 2.89% | 4 |
|
|
2017
Q4 | $58.3M | Sell |
1,696,927
-156,437
| -8% | -$5.33M | 2.79% | 5 |
|
|
2017
Q3 | $62.8M | Sell |
1,853,364
-2,932
| -0.2% | -$94.2K | 2.87% | 4 |
|
|
2017
Q2 | $59.2M | Sell |
1,856,296
-34,677
| -2% | -$1.09M | 2.5% | 6 |
|
|
2017
Q1 | $61.4M | Buy |
1,890,973
+4,638
| +0.2% | +$146K | 2.62% | 6 |
|
|
2016
Q4 | $58.1M | Buy |
1,886,335
+10,118
| +0.5% | +$309K | 2.57% | 6 |
|
|
2016
Q3 | $60.3M | Sell |
1,876,217
-18,482
| -1% | -$618K | 2.71% | 6 |
|
|
2016
Q2 | $63.3M | Sell |
1,894,699
-40,184
| -2% | -$1.28M | 2.84% | 5 |
|
|
2016
Q1 | $54.4M | Sell |
1,934,883
-12,790
| -0.7% | -$365K | 2.52% | 6 |
|
|
2015
Q4 | $59.6M | Sell |
1,947,673
-21,164
| -1% | -$666K | 2.82% | 5 |
|
|
2015
Q3 | $58.7M | Sell |
1,968,837
-10,785
| -0.5% | -$346K | 2.97% | 6 |
|
|
2015
Q2 | $63M | Sell |
1,979,622
-19,204
| -1% | -$626K | 2.88% | 5 |
|
|
2015
Q1 | $66M | Sell |
1,998,826
-44,218
| -2% | -$1.41M | 2.99% | 5 |
|
|
2014
Q4 | $60.4M | Sell |
2,043,044
-1,307
| -0.1% | -$37.5K | 2.71% | 6 |
|
|
2014
Q3 | $57.4M | Buy |
2,044,351
+453
| +0% | +$12.7K | 2.66% | 7 |
|
|
2014
Q2 | $57.6M | Buy |
2,043,898
+18,911
| +0.9% | +$539K | 2.66% | 7 |
|
|
2014
Q1 | $61.7M | Sell |
2,024,987
-10,329
| -0.5% | -$308K | 2.96% | 7 |
|
|
2013
Q4 | $59.1M | Sell |
2,035,316
-61,343
| -3% | -$1.79M | 2.87% | 7 |
|
|
2013
Q3 | $57.1M | Sell |
2,096,659
-13,913
| -0.7% | -$379K | 3.04% | 6 |
|
|
2013
Q2 | $56.1M | Buy |
+2,110,572
| New | +$58.3M | 3.08% | 7 |
|
Other funds holding PFE
VCM
VPM
Meyer Handelman Company's PFE Position: Q1 2026 in Review
Meyer Handelman Company reduced its Pfizer (PFE) stake by 5% in Q1 2026, selling an estimated $1.57M and leaving 1,127,840 shares worth $31.7M. The position accounts for 0.98% of the portfolio, ranked #36.
Meyer Handelman Company first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $83M in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Meyer Handelman Company held 1,127,840 shares of Pfizer worth $31.7M as of Q1 2026.
- Meyer Handelman Company sold 58,975 Pfizer shares in Q1 2026, an estimated $1.57M.
- Pfizer made up 0.98% of Meyer Handelman Company's portfolio in Q1 2026, its #36 holding.
- Meyer Handelman Company first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Meyer Handelman Company's Pfizer position peaked at $83M in Q4 2021.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Meyer Handelman Company's 13F filing for Q1 2026, filed 20 Apr 2026.